nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Cognitive Disorders"

 

Greater Cortical Thickness in Elderly Female Yoga Practitioners
July 22, 2017   

Yoga, mind-body activity has been associated with positive changes in brain structure and function, especially in areas related to attention, executive functions, and memory. Normal aging corresponds with structural and functional brain changes, that involve decreased cognitive function. In a recent cross-sectional study...
 Continue reading (Members only)
A Cross-Sectional Comparison of Brain Glucose and Ketone Metabolism in Cognitively Healthy Older Adults, Mild Cognitive Impairment (MCI) and Early Alzheimer’s Disease (AD)
July 19, 2017   

Deteriorating brain glucose metabolism precedes the clinical onset of AD and contributes to its etiology. Ketone bodies, mainly ß-hydroxybutyrate and acetoacetate are the primary alternative fuel to glucose. In a recent study...
 Continue reading (Members only)
Predicting the Risk of Mild Cognitive Impairment- Mayo Clinic Study of Aging
July 16, 2017   

A recent longitudinal study conducted by the Mayo Clinic examined approximately 1500 participants to develop risk scores for the progression from cognitively normal (CN) to mild cognitive impairment (MCI)...
 Continue reading (Members only)
Physical Exercise and Cognitive Function in Older Adults: Meta-Analysis
May 1, 2017   

A new meta-analysis has shown that physical exercise improves cognitive functioning in healthy adults over the age of 50...
 Continue reading (Members only)
Collaborative Care for Persistent Postconcussive Symptoms in Adolescents
December 8, 2016   

Sports-related concussions are often associated with postconcussive psychological symptoms, yet there is no evidence-based treatment for postconcussive symptoms in children and adolescents. A recent study tested a collaborative care intervention model...
 Continue reading (Members only)
CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer’s Disease and Cerebrovascular Disease
December 3, 2016   

In a recent study, patients with Alzheimer’s disease (AD) or cognitive impairment due to cerebrovascular disease (CVD) were treated with a medical food therapy for hyperhomocysteinemia (HHcy)...
 Continue reading (Members only)
Glia-Mediated Brain Inflammation after Repeated Concussions Detected In Vivo
December 1, 2016   

Microglia, the immune cells of the central nervous system, play a primary role in the brain’s response to injury and neurodegenerative processes. Single and repeated traumatic brain injuries may result in microglial activation...
 Continue reading (Members only)
FDA Alert: Medication and Medical Device Approvals
September 12, 2016   

The US FDA has approved the marketing of computerized cognitive tests to assess for possible concussions, granted tentative approval for Trokendi XR for migraine prevention, and approved abuse-deterrent Troxyca ER for severe pain management.
 Continue reading (Members only)
Most Children With TBI Present to Primary Care, Not Emergency Department
June 23, 2016   

A four-year study recently published by researchers from the Children’s Hospital of Philadelphia (CHOP) and the U.S. Centers for Disease Control and Prevention (CDC) found that 81.9% of children had their first concussion visit within primary care. The Children’s Hospital of Philadelphia encompasses over 50 locations including 31 primary care centers, 14 specialty care center, 2 emergency departments (ED), 2 urgent care centers, and a 535-bed inpatient hospital. Researchers examined...
 Continue reading (Members only)
What's New in Cognitive Research
April 11, 2016   

The Phase 3 results for encenicline--under investigation for cognitive symptoms in schizophrenia--were not as hoped. In other cognitive news, a recent study shows a link between physical activity and cognitive decline.
 Continue reading (Members only)
Top of Page